{"id":"W2946829725","doi":"10.1158/1078-0432.ccr-18-3212","title":"Pharmacodynamic and Clinical Results from a Phase I/II Study of the HSP90 Inhibitor Onalespib in Combination with Abiraterone Acetate in Prostate Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute; National Institute for Health and Care Research; Cancer Research UK; Astex Pharmaceuticals","keywords":"Abiraterone acetate; Prostate cancer; Pharmacodynamics; Abiraterone; Medicine; Cancer; Prostate; Oncology; Internal medicine; Pharmacology; Pharmacokinetics; Androgen deprivation therapy; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004582386,0.0002099648,0.0007857633,0.0002758882,0.0001005844,0.00002899266,0.000287522,0.000142593,0.0001162481],"category_scores_gemma":[0.0003780731,0.0001246493,0.00008459351,0.001091954,0.000754286,0.0001457785,0.0004139463,0.001925698,0.000009431659],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004086765,"about_ca_system_score_gemma":0.001285982,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00775881,"about_ca_topic_score_gemma":0.01270095,"domain_scores_codex":[0.9946039,0.001356856,0.001361483,0.0009092374,0.001172929,0.0005955709],"domain_scores_gemma":[0.997239,0.001238856,0.0002332609,0.0005755301,0.0004688425,0.0002445443],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05293656,0.009533918,0.8965112,0.0001206965,0.0002089558,0.0001134748,0.00184755,0.00002819476,0.001631575,0.000002996873,0.000258527,0.03680634],"study_design_scores_gemma":[0.1468984,0.01549231,0.8317275,0.001192208,0.00007362063,0.00000130845,0.001126327,0.001769454,0.0009023673,0.0000681349,0.0005832872,0.0001650465],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9881914,0.001311635,1.38951e-7,0.004978815,0.0002968599,0.004860263,0.000225818,0.00001320022,0.0001219083],"genre_scores_gemma":[0.9923242,0.004853456,0.00001439047,0.0001023809,0.0001435571,0.0004530615,0.00003989094,0.00003713529,0.00203194],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0939619,"threshold_uncertainty_score":0.9988486,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1538357423929069,"score_gpt":0.5354631624239391,"score_spread":0.3816274200310322,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}